image Follow Us:

lsnlogo2short

Byetta, Januvia, Victoza Pancreatitis and Pancreatic Cancer Cases

byetta-man

MT Services LLC provides up-to-date lawsuit news on all of the various bad diabetes drug; as well as various services to assist victims with getting the help they need during this difficult time. These services include: Lawsuit Pre-Settlement Funding Cash Advances, surgery procedure funding (or cash needs related to your surgery), and Attorney Referrals to Nationally recognized Byetta, Januvia, and Victoza - or other diabetes drug law firms.

Type 2 Diabetes Drugs Risks

In 2007, The U.S. Food and Drug Administration began issuing alerts regarding their concerns of increased risk of acute pancreatitis in patients taking Byetta which is manufactured by Amylin Pharmaceuticals.

In 2009, the FDA received 88 complaints of patients being diagnosed with pancreatitis after taking Januvia, prompting the FDA to issue a warning that taking Januvia could lead to pancreatitis – which could ultimately manifest into Pancreatic Cancer.

In 2011, a University of California study thoroughly reviewed data compiled by the FDA regarding “adverse events” and concluded that patients who used Byetta or Januvia had 3x’s the risk of pancreatic cancer.


Products and Manufacturers

Diabetes control medications make up approximately $40 billion in annual sales in the United States alone. There are dozens of various diabetes drugs on the market and to date, most of them have not been recalled by the FDA and present risk to many patients. Although there have been some studies that show that many diabetics are already at risk for acute pancreatitis or pancreatic cancer, law firms in our network are still actively pursuing claims against the manufactures, some who are creating billions of annual sales.

Most of the claims revolve around the fact that manufacturers did not proper warn the patients of the various cancer (and other) risks, such as:

  • Pancreatitis
  • Pancreatic Cancer
  • Thyroid Cancer

Here are just some of the products and manufactures that lawyers in MTS’s network are pursuing claims against:  

  • Byetta, Amylin and Ely Lilly Pharmaceuticals
  • Boston Scientific Inc.
  • Januvia, Merck & Company
  • Victoza, Novo Nordisk
  • Onglyza, Bristol Myers Squibb
  • Kombiglyze, Bristol Myers Squibb
  • Nesina, Takeda Pharmaceuticals
  • Kazano, Takeda Pharmaceuticals
  • Tradjenta, Boehringer Ingelheim
  • Jentadueto, Boehringer Ingelheim

Need Lawsuit Help on a Potential Diabetes Drug/Pancreatitis or Pancreatic Cancer Claim?

Lawyers have begun filing 100’s lawsuits against many of the drug manufactures listed above in both State and Federal Courts throughout the country, including California and Illionis. The suits target the drugs: Byetta, Januvia, Victoza, and other “incretin-based therapy” drugs. If you or a loved one is uncertain if you may have a claim and need a free legal consultation from a top Victoza, Januvia, or Byetta law firm or lawyer, fill out the application on the upper right hand side of this page and an agent will contact you promptly. If you prefer to speak with a live agent right now, contact our offices toll-free at: 877.571.0405 where live agents are standing by to answer any of your questions and guide you to a competent law firm immediately.

Need Financial Help on Your Pending Byetta, Januvia ,or Victoza Lawsuit?

Pharmaceutical Companies are notorious for dragging out bad drug litigation for years, and in some cases decades. If you need cash today on your lawsuit, MTS can assist you if you have already retained a diabetes drug law firm. All you need to do is fill out the application on the right hand side of this page or call our toll-free hotline at: 877.571.0405 and an agent will promptly assist you with getting you the pre-settlement funding you need today. Lawsuit Settlement Funding Companies in our network are taking applications for lawsuit cash advances up to $50K on any Byetta, Januvia, or Victoza cases.

Please read our Disclosure Statement located on the footer of our website which outlines the terms and conditions regarding our various vendor relationships.

Topic Feeds

Loading feeds...